Testing effectiveness (Phase 2)Ended earlyNCT05553639
What this trial is testing
HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer
Who this might be right for
Prostate Cancer Metastatic
Hookipa Biotech GmbH 12